Chi Ngai Chan

Company: Beth Israel Deaconess Medical Center

Job title: Director, Tissue Technologies Unit

Bio:

I am the Director of the Tissue Technologies Unit (TTU) at Beth Israel Deaconess Medical Center, Harvard Medical School. Our mission is to support researchers in uncovering disease mechanisms using cutting-edge, high-plex spatial omics technologies.

I earned my Ph.D. in Virology from the University of Glasgow, then moved to the U.S. to pursue my research in HIV latency and cure. I held postdoctoral positions at New York University and the Frederick National Laboratory for Cancer Research, before joining Oregon Health & Science University. There, I contributed to the development of novel spatial biology techniques such as FISSEQ and PANINI.

Bringing my spatial omics and preclinical research experience to Boston, I established TTU as a core facility that harnesses the most advanced spatial transcriptomics and proteomics platforms to address key questions in disease biology – using the most relevant in vivo and clinical samples.

Seminars:

Generating High-Quality Spatial Multi-Omic Data: Experimental Strategies to Enable Meaningful Discovery in Oncology Research 4:15 pm

How can experimental design be optimized to improve multi-omics spatial data outputs? What lessons can be learned from high-quality case studies in oncology applications? How does cross-platform integration strengthen target discovery and patient stratification?Read more

day: Day One